Followers | 827 |
Posts | 119554 |
Boards Moderated | 15 |
Alias Born | 09/05/2002 |
Monday, July 17, 2023 1:39:21 PM
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Recent PRDS News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 09/11/2023 12:00:13 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 08/31/2023 09:17:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/31/2023 06:44:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/31/2023 06:32:33 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 08/31/2023 01:06:57 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 08/31/2023 01:03:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/31/2023 12:59:52 PM
- Form SC TO-T/A - Tender offer statement by Third Party: [Amend] • Edgar (US Regulatory) • 08/31/2023 12:53:51 PM
- Form SC 13E3/A - Going private transaction by certain issuers: [Amend] • Edgar (US Regulatory) • 08/31/2023 12:34:23 PM
- Form SC 14D9/A - Solicitation, recommendation statements: [Amend] • Edgar (US Regulatory) • 08/31/2023 12:30:50 PM
- Pardes Biosciences Announces Closing of Tender Offer • GlobeNewswire Inc. • 08/31/2023 12:15:00 PM
- Form SC 13E3/A - Going private transaction by certain issuers: [Amend] • Edgar (US Regulatory) • 08/28/2023 04:11:56 PM
- Form SC 14D9/A - Solicitation, recommendation statements: [Amend] • Edgar (US Regulatory) • 08/28/2023 04:08:26 PM
- Form SC TO-T/A - Tender offer statement by Third Party: [Amend] • Edgar (US Regulatory) • 08/28/2023 03:52:35 PM
- MediPacific Offering $2.13 Per Share Plus One Contingent Value Right Per Share in Tender Offer for Pardes Biosciences • Business Wire • 08/28/2023 03:33:00 PM
- MediPacific Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Pardes Biosciences Shares • Business Wire • 08/17/2023 09:43:00 PM
- Form SC 13E3/A - Going private transaction by certain issuers: [Amend] • Edgar (US Regulatory) • 08/17/2023 09:11:54 PM
- Form SC 14D9/A - Solicitation, recommendation statements: [Amend] • Edgar (US Regulatory) • 08/17/2023 09:09:01 PM
- Form SC TO-T/A - Tender offer statement by Third Party: [Amend] • Edgar (US Regulatory) • 08/17/2023 08:59:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/04/2023 08:03:56 PM
- Form SC 13E3 - Going private transaction by certain issuers • Edgar (US Regulatory) • 07/28/2023 09:08:05 PM
- Form SC 14D9 - Solicitation, recommendation statements • Edgar (US Regulatory) • 07/28/2023 09:04:58 PM
- Form SC TO-T - Tender offer statement by Third Party • Edgar (US Regulatory) • 07/28/2023 09:01:41 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM